These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


147 related items for PubMed ID: 18211977

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes.
    Mumm H, Jensen DM, Sørensen JA, Andersen LL, Ravn P, Andersen M, Glintborg D.
    Acta Obstet Gynecol Scand; 2015 Feb; 94(2):204-11. PubMed ID: 25417943
    [Abstract] [Full Text] [Related]

  • 4. Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome.
    Zhao X, Zhong J, Mo Y, Chen X, Chen Y, Yang D.
    Int J Gynaecol Obstet; 2010 Feb; 108(2):148-51. PubMed ID: 19932893
    [Abstract] [Full Text] [Related]

  • 5. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.
    Azziz R.
    J Clin Endocrinol Metab; 2006 Mar; 91(3):781-5. PubMed ID: 16418211
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women.
    Liou TH, Yang JH, Hsieh CH, Lee CY, Hsu CS, Hsu MI.
    Fertil Steril; 2009 Dec; 92(6):1960-5. PubMed ID: 18980763
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in the Croatian population.
    Baldani DP, Skrgatić L, Simunić V, Zlopasa G, Canić T, Trgovcić I.
    Coll Antropol; 2013 Jun; 37(2):477-82. PubMed ID: 23940993
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Correlation of clinical and biochemical hyperandrogenism in Thai women with polycystic ovary syndrome.
    Leerasiri P, Wongwananuruk T, Indhavivadhana S, Techatraisak K, Rattanachaiyanont M, Angsuwathana S.
    J Obstet Gynaecol Res; 2016 Jun; 42(6):678-83. PubMed ID: 26890011
    [Abstract] [Full Text] [Related]

  • 20. High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria?
    Busiah K, Colmenares A, Bidet M, Tubiana-Rufi N, Levy-Marchal C, Delcroix C, Jacquin P, Martin D, Benadjaoud L, Jacqz-Aigrain E, Laborde K, Robert JJ, Samara-Boustani D, Polak M.
    Horm Res Paediatr; 2017 Jun; 87(5):333-341. PubMed ID: 28437788
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.